Takasaki, Japan

Shinichiro Kato


Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 156(Granted Patents)


Location History:

  • Maebashi, JP (1989)
  • Takasaki, JP (2000)

Company Filing History:


Years Active: 1989-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Shinichiro Kato

Introduction

Shinichiro Kato is a notable inventor based in Takasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential therapeutic applications. With a total of 2 patents, Kato's work focuses on innovative solutions to complex medical challenges.

Latest Patents

Kato's latest patents include groundbreaking research on quinoline and quinazoline derivatives that inhibit platelet-derived growth. Additionally, he has developed a method for treating amnesia using a pyrrolidone derivative. This derivative is represented by a specific formula, where R denotes a group, X represents either --SO.sub.2 -- or --CO--, and R' can be a hydrogen atom, a lower alkyl group, a trifluoromethyl group, a halogen atom, or a nitro group. The versatility of these compounds showcases Kato's innovative approach to addressing cognitive disorders.

Career Highlights

Throughout his career, Shinichiro Kato has been associated with Kirin Beer Kabushiki Kaisha, where he has contributed to various research initiatives. His work has not only advanced the understanding of certain chemical compounds but has also paved the way for potential new treatments in the medical field.

Collaborations

Kato has collaborated with esteemed colleagues such as Kazuo Kubo and Shinichi Ohyama. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research.

Conclusion

Shinichiro Kato's contributions to the field of pharmaceuticals through his innovative patents highlight his dedication to improving medical treatments. His work continues to inspire future research and development in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…